Follow
PTEN
PTEN is a human gene coding for an enzyme called phosphatase and tensin homolog (PTEN). PTEN in a tumor suppressor gene which prevents mutations from occurring in genetic code. Therefore, mutations in PTEN are prevalent in many malignancies including brain, breast, lung, and prostate cancers.
What's Popular in PTEN
MAY 19, 2020 | 12:45 PM
Background: Pathologists have long recognized that the interaction between immune and tumour cells is critical in the development and progression of breast cancer. Studies have demonstrated...
APR 10, 2019 | 12:00 PM
Determining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...
OCT 11, 2018 | 9:00 AM
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
OCT 11, 2018 | 9:00 AM
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
MAR 15, 2018 | 9:00 AM
The inability of neurons to regenerate damaged axons within the CNS has dire consequences for victims of traumatic or ischemic brain injury and multiple neurodegenerative diseases. Like other...
OCT 12, 2017 | 10:30 AM
Pancreatic ductal adenocarcinoma (PDAC) has a five-year survival rate of only 9%. Acquired drug resistance is a major factor that limits the effectiveness of chemotherapy. Exosomes, secreted...
